Article info
Clinical science
Short-term choroidal thickness changes in patients treated with either ranibizumab or aflibercept: a comparative study
- Correspondence to Dr Tae Gon Lee, Department of Ophthalmology, Kim's Eye Hospital, #156 Youngdeungpo-dong 4ga, Youngdeungpo-gu, Seoul 150-034, South Korea; tglee85{at}naver.com
Citation
Short-term choroidal thickness changes in patients treated with either ranibizumab or aflibercept: a comparative study
Publication history
- Received November 3, 2015
- Revised January 7, 2016
- Accepted February 10, 2016
- First published March 7, 2016.
Online issue publication
February 19, 2018
Article Versions
- Previous version (19 February 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/